Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PSORIASIS”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT03925441
What this trial is testing

Post-Marketing Surveillance Study of Adalimumab in Pediatric Chronic Severe Plaque Psoriasis Patients in Korea

Who this might be right for
Psoriasis
AbbVie 2
Not applicableStudy completedNCT03378336
What this trial is testing

Psoriatic Arthritis Research Collaborative: Biologic Sub-Study

Who this might be right for
Psoriatic Arthritis
University of Pennsylvania 171
Not applicableStudy completedNCT02274363
What this trial is testing

Assess the Severity of Psoriasis in Brazilians Participants With Chronic Plaque-type Psoriasis

Who this might be right for
PsoriasisPlaque
Janssen Pharmaceutica 1,131
Not applicableStudy completedNCT03389984
What this trial is testing

Psoriatic Inflammation Markers Predictive of Response to Adalimumab

Who this might be right for
Psoriasis Vulgaris
Poitiers University Hospital 85
Post-approval studies (Phase 4)Study completedNCT01893567
What this trial is testing

Subject Reported Target-lesion Numeric Rating Scale Evaluation by Subjects With Plaque Psoriasis Treated With Clobex® (Clobetasol Propionate) Spray 0.05%

Who this might be right for
Plaque Psoriasis
Galderma R&D 28
Testing effectiveness (Phase 2)Ended earlyNCT06380907
What this trial is testing

ZL-1102 in Patients With Chronic Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Zai Lab (Hong Kong), Ltd. 65
Not applicableUnknownNCT05225493
What this trial is testing

HIV Indicator Diseases in Hospital and Primary Care

Who this might be right for
HIV InfectionsPrimary Health CareAcquired Immunodeficiency Syndrome+15 more
Erasmus Medical Center 1,500
Large-scale testing (Phase 3)Study completedNCT00111449
What this trial is testing

Evaluating the Safety of Etanercept 50 mg Twice Weekly in Subjects With Psoriasis

Who this might be right for
Psoriasis
Amgen 600
Testing effectiveness (Phase 2)Ended earlyNCT02243787
What this trial is testing

Safety and Tolerability Study of COVA322 in Patients With Stable Chronic Moderate-to-severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Covagen 24
Large-scale testing (Phase 3)Study completedNCT06049810
What this trial is testing

IBI112 in Moderate to Severe Plaque Psoriasis With Randomized Withdrawal and Re-treatment

Who this might be right for
Psoriasis
Innovent Biologics (Suzhou) Co. Ltd. 566
Post-approval studies (Phase 4)Study completedNCT00493324
What this trial is testing

Study to Evaluate the Immune Response to Pneumococcal Vaccine in Alefacept-treated Adults With Chronic Plaque Psoriasis

Who this might be right for
Chronic Plaque Psoriasis
Astellas Pharma Inc 43
Post-approval studies (Phase 4)Study completedNCT00581100
What this trial is testing

Effects of Etanercept on Nail Psoriasis and Plaque Psoriasis

Who this might be right for
Nail PsoriasisPlaque Psoriasis
Wyeth is now a wholly owned subsidiary of Pfizer 136
Large-scale testing (Phase 3)Study completedNCT01782937
What this trial is testing

An Open-label, Non-controlled Study of KHK4827 in Subjects With Psoriasis

Who this might be right for
Psoriasis
Kyowa Kirin Co., Ltd. 30
Large-scale testing (Phase 3)Study completedNCT01008995
What this trial is testing

The Safety and Effectiveness of Ustekinumab (Stelara) in Chinese Patients With Psoriasis

Who this might be right for
Psoriasis
Centocor, Inc. 322
Not applicableStudy completedNCT01202565
What this trial is testing

Effectiveness of Adalimumab (HUMIRA®) in the Treatment of Scalp and Nail Affection in Patients With Moderate to Severe Plaque Psoriasis in Routine Clinical Practice

Who this might be right for
Moderate to Severe Plaque Psoriasis
AbbVie (prior sponsor, Abbott) 506
Testing effectiveness (Phase 2)Study completedNCT01722812
What this trial is testing

Cromoglicate in Psoriasis

Who this might be right for
Psoriasis
LEO Pharma 30
Not applicableLooking for participantsNCT07683065
What this trial is testing

Estimate Secukinumab Retention Rate in Psoriasis Patients With MASLD

Who this might be right for
Plaque PsoriasisMetabolic Dysfunction-Associated Steatotic Liver Disease
Novartis Pharmaceuticals 150
Not applicableActive Not RecruitingNCT06952465
What this trial is testing

A Study Comparing the Risk of Serious Infections and Malignancies With Deucravacitinib or Biologics in Japanese Patients With Psoriasis

Who this might be right for
Psoriasis
Bristol-Myers Squibb 2,000
Testing effectiveness (Phase 2)Study completedNCT02933502
What this trial is testing

Safety Study in Patients With Scalp Psoriasis Suppression Following Maximal Use Treatment With Topical Product

Who this might be right for
Scalp Psoriasis
Sun Pharmaceutical Industries, Inc. 3
Large-scale testing (Phase 3)Study completedNCT02886702
What this trial is testing

A Study Comparing Tazarotene Cream 0.05% to TAZORAC® (Tazarotene) Cream 0.05% and Both to a Placebo Control in the Treatment of Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Fougera Pharmaceuticals Inc. 855
Next Page